Sensitivity and specificity for various renal-related diagnoses (values are compared with an eGFR <60 mL/min per 1.73 m2) Diagnosis Sensitivity (%) Specificity.

Slides:

Advertisements

Similar presentations

What Happens to the Performance of a Diagnostic Test when the Disease Prevalence and the Cut-Point Change? Pathological scores Healthy scores Healthy population.

Advertisements

Diagnosis Examination(MMSE) in detecting dementia among elderly patients living in the community. Excel.

Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.

© 2016 S. Karger AG, Basel. All rights reserved Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency.

Preventive Measures Infection & Delayed Wound Healing Frequent dental visits to assess plaque control Risk assessment profiles to identify risk factors.

The LIVES Sub-analysis

EVALUATION OF SOLUBLE CD14 SUBTYPE (PRESEPSIN)

A.M. Thompson, T.G. Pickering Kidney International

Pathogenesis of bone diseases in chronic kidney disease

Characteristics IgAN (n=28) ADPKD (n=37) Male (percentage) 21 (75.0)

CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.

Renal Parenchymal Hypoxia, Hypoxia Response and the Progression of Chronic Kidney Disease Am J Nephrol 2008;28:998– DOI: / © 2008.

Section 3: CKD, CVD and mortality

Metformin Use in Chronic Kidney Disease

Chronic Kidney Disease is Common and Expensive and Interacts with Diabetes and Cardiovascular Disease in the Dually-Enrolled Population Funded in part.

From: Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate.

Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency.

Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast‐Induced Acute Kidney Injury After Percutaneous Coronary Intervention.

End point Patients >75 y with renal insufficiency

Hint: Numerator Denominator. Vascular Technology Lecture 34: Test Validation (Statistical Profile and Correlation) HHHoldorf.

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Figure 4 Expression of coagulation protease receptors in renal cells

Kuwabara et al. Am J Nephrol 2017;45: (DOI: / )

تحليل الحساسية Sensitive Analysis.

Median NT-proBNP levels (pg/mL) by GFR and 60-day survival

Creatinine clearance (mL/min) n All-cause mortality (%)

Bhandari et al. Am J Nephrol 2017;45: (DOI: / )

Millie D. Long, Bruce E. Sands

Nat. Rev. Nephrol. doi: /nrneph

Change in mean LVMI with erythropoietin alpha hemoglobin maintenance treatment and control/delayed treatment from baseline to 24 months End point Hemoglobin.

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology.

Variable Pretreatment Posttreatment P GFR (mL/min) 115±18 102±14 NS

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Figure 2 The network of chronic diseases and their mutual influences

Figure 1 The burden of chronic kidney disease (CKD)

Figure 1 Acute kidney injury and chronic kidney disease

Several microRNAs are differentially expressed in the glomeruli between different types of kidney disease. Several microRNAs are differentially expressed.

Trial analysis results comparing ACE inhibitors/ARBs with other antihypertensive drugs on renal disease progression End point Relative risk (95% CI) p.

Figure 1. Table for calculating the accuracy of a diagnostic test.

A Pathological Scoring System to Predict Renal Outcome in Diabetic Nephropathy Am J Nephrol 2015;41: DOI: / Fig. 1. Renal survival.

End point Fenoldopam, n (%) Dopamine, n (%) p

A New Clinical Prediction Tool for 5-Year Kidney Transplant Outcome

Your Kidneys May Outlive You

AMACING Trial design: Patients with chronic kidney disease undergoing intravascular iodinated contrast administration were randomized to prophylactic hydration.

Figure 3 Serum phosphate level is associated with

This Month in AJKD American Journal of Kidney Diseases

(A) Kaplan-Meier renal survival estimates of patients with diabetic nephropathy (DN), non-diabetic renal disease (NDRD) and mixed groups, adjusting for.

Management of Heart Failure in Advancing CKD: Core Curriculum 2018

Langsford et al. Am J Nephrol 2017;45: (DOI: / )

Volume 76, Issue 10, Pages (November 2009)

Classification by HtTKV0 and age at HtTKV0 predicts the change in eGFR over time in class 1 patients. Classification by HtTKV0 and age at HtTKV0 predicts.

Nowak et al. Am J Nephrol 2016;44: (DOI: / )

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Schematic of screening program for diabetes mellitus (DM) during acute myocardial infarction (AMI). Schematic of screening program for diabetes mellitus.

Dengue pre-vaccination screening and positive predictive values

UMOD and ACSM2A expressions correlate with renal function.

Serum 25(OH)D levels stratified by the presence or absence of nephropathy. Serum 25(OH)D levels stratified by the presence or absence of nephropathy. The.

Fig. 1 Intrarenal lymphangiogenesis in patients with CKD accompanied by intrarenal inflammatory cells and renal fibrosis. Intrarenal lymphangiogenesis.

Ann M. O'Hare, MA, MD American Journal of Kidney Diseases

Low/moderate intensity statins High intensity statins

Michael Reed et al. JCIN 2009;2:

Diagnostic performance of dentist clinical impression.

Relationship between time from diagnosis of type 2 diabetes to renal biopsy and the proportion of biopsies with any diabetic nephropathy (DN) and any non-diabetic.

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Risk of 30-day hospital encounter with ventricular arrhythmia

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Diagnostic criteria for AKI

Avasare et al. Am J Nephrol 2017;45:99-106 (DOI: / )

Presentation transcript:

Sensitivity and specificity for various renal-related diagnoses (values are compared with an eGFR <60 mL/min per 1.73 m2) Diagnosis Sensitivity (%) Specificity (%) PPV (%) NPV (%) DN 1.7 99 79.3 32.2 ARF 3.9 99.7 96.3 32.8 HypN 4.8 99.5 95.5 33 CRI 9.1 99.6 98.4 34.1 MISC 13.3 97.6 92.1 34.7 DN=diabetic nephropathy ARF=hypertensive nephropathy HypN=acute renal failure CRI=chronic renal insufficiency MISC=miscellaneous other renal disease PPV=positive predictive values NPV=negative predictive values Winkelmayer W et al. Am J Kidney Dis 2005: 46:225-232.